Download Free Medical Genetics made easy-demystifying genetic testing PowerPoint Presentation

Genetics made easy-demystifying genetic testing PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Genetics, which is titled "Genetics made easy: demystifying genetic testing", to learn about the role of clinical and molecular genetics, how to arrange genetic testing, and interpreting results.

Tags : Genetics, genetic testing, clinical, molecular genetics

Published on : Aug 29, 2021 | Views : 2690 | Downloads : 5

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Genetics made easy: demystifying genetic testing Dr Catherine McWilliam Dawn O’Sullivan
Slide 2-

Workshop Aims An overview of the role of clinical and molecular genetics How to arrange genetic testing Interpreting results Case examples
Slide 3-

Inherited Cardiac Disease Hypertrophic Cardiomyopathy Around 50% maybe caused by a dominantly inherited pathogenic variant Familial Arrhythmia Long QT syndrome Brugada Arrhythmogenic right ventricular dysplasia/cardiomyopathy Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Inherited aortopathies Marfan, Loeys Dietz Dilated Cardiomyopathy Fewer genetic causes but worth considering Congenital cardiac disease
Slide 4-

Genetic Testing: What are the pro’s and cons?
Slide 5-

Genetic Testing: pros and cons Pros To allow identification of at risk relatives Targeted screening Allowing early diagnosis and intervention Confirm diagnosis Cons At risk relatives may not wish to know May not clarify diagnosis if variant of uncertain significance identified Feelings of guilt if passed on to younger generation Predictive testing may turn the ‘well’ individual into a patient Employment/Finance/ Insurance issues
Slide 6-

ppt slide no 6 content not found
Slide 7-

ppt slide no 7 content not found
Slide 8-

Consent: What do we need to think about?
Slide 9-

Consent To a specific test Information to be shared with other family members on request of their doctor Information to be used to allow accurate testing of family members To DNA storage For DNA to be used for validating test (ie within the lab, anonymously) For DNA to be used in research
Slide 10-

Cardiac Arrhythmia screening in Scotland Long QT (LQTS) development Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) development Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) development Cardiac Arrhythmia NGS
Slide 11-

Cardiac Arrhythmia Subpanels
Slide 12-

Variant classification Implementation of NGS (bigger panels) results in more Variants of Uncertain Clinical Significance (VUS) Very little evidence available in the literature / databases Guidelines are intended for general use in classifying variants in patients with rare diseases. Disease-specific guidelines are being developed for disorders where different evidence thresholds are required, e.g. cardiac disorders Still framework open to interpretation and need for professional judgement
Slide 13-

Variant classification system *currently under review within the Scottish Consortium
Slide 14-

Variant classification Rules where clinical input required PS2 De novo (both maternity and paternity confirmed) in patient with the disease and no FH PM6 Assumed de novo, but without confirmation of paternity and maternity PP1 Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (may be used as stronger evidence with increasing segregation data) PP4 Patient’s phenotype or family history is highly specific for a disease with a single genetic etiology Greater need for good clinical and laboratory communication Regular MDTs (lab, clinical genetics, other specialists) / VUS classification meetings Details in referral important: patient phenotype if known and what clinical tests carried out, specific relationship to the patient, segregation data This evidence must be formally recorded rather than verbal communication Likely to be a change in how VUS are reported but communication will still be essential
Slide 15-

Cases
Slide 16-

Learning point Variant reclassification
Slide 17-

Learning point Availability of genetic testing is expanding It can be worth looking again….
Slide 18-

Learning point Beware the non-informative family history Complexities of cascade screening in a new diagnosis
Slide 19-

Learning point Cascade screening in a timely manner/as suggested by the presentation
Slide 20-

Summary Genetic testing can be very helpful to support diagnosis and target screening for family members Molecular genetics is complex and not always easily interpretable – if in doubt please ask! Patients and families can find this complexity difficult and it is better to make them aware of the possibility of ‘variant of unknown significance’ at the start of the journey